Capital Performance Advisors »

Aurinia Pharmaceuticals shares owned by Capital Performance Advisors

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Capital Performance Advisors from 13F filings

Historical chart of Capital Performance Advisors investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Capital Performance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.7k 1.2k 7.33

More positions owned by Capital Performance Advisors

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Specialized Funds Div App Etf (VIG)
Dimensional Etf Trust World Ex Us Core (DFAX)
Amazon (AMZN)

View all positions for Capital Performance Advisors

Top funds holding Aurinia Pharmaceuticals

Armistice Capital
BlackRock
BlackRock
Tang Capital Management
NEA Management Company
State Street Corporation
Goldman Sachs Group
Nuveen Asset Management
Geode Capital Management
Vanguard Group
Rock Springs Capital Management
Susquehanna International
Citadel Advisors
Schroder Investment Management Group
Northern Trust

View all funds holding Aurinia Pharmaceuticals